Cargando…
Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations
Whole exome sequencing (WES) of matched tumor-normal pairs in rare tumors has the potential to identify genome-wide mutations and copy number alterations (CNAs). We evaluated 27 rare cancer patients with tumor-normal matching by WES and tumor-only next generation sequencing (NGS) as a comparator. Ou...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352311/ https://www.ncbi.nlm.nih.gov/pubmed/32570879 http://dx.doi.org/10.3390/cancers12061618 |
_version_ | 1783557608149352448 |
---|---|
author | Sprissler, Ryan Perkins, Bryce Johnstone, Laurel Babiker, Hani M. Chalasani, Pavani Lau, Branden Hammer, Michael Mahadevan, Daruka |
author_facet | Sprissler, Ryan Perkins, Bryce Johnstone, Laurel Babiker, Hani M. Chalasani, Pavani Lau, Branden Hammer, Michael Mahadevan, Daruka |
author_sort | Sprissler, Ryan |
collection | PubMed |
description | Whole exome sequencing (WES) of matched tumor-normal pairs in rare tumors has the potential to identify genome-wide mutations and copy number alterations (CNAs). We evaluated 27 rare cancer patients with tumor-normal matching by WES and tumor-only next generation sequencing (NGS) as a comparator. Our goal was to: 1) identify known and novel variants and CNAs in rare cancers with comparison to common cancers; 2) examine differences between germline and somatic variants and how that functionally impacts rare tumors; 3) detect and characterize alleles in biologically relevant genes-pathways that may be of clinical importance but not represented in classical cancer genes. We identified 3343 germline single nucleotide variants (SNVs) and small indel variants—1670 in oncogenes and 1673 in tumor suppressor genes—generating an average of 124 germline variants/case. The number of somatic SNVs and small indels detected in all cases was 523:306 in oncogenes and 217 in tumor suppressor genes. Of the germline variants, six were identified to be pathogenic or likely pathogenic. In the 27 analyzed rare cancer cases, CNAs are variable depending on tumor type, germline pathogenic variants are more common. Cell fate pathway mutations (e.g., Hippo, Notch, Wnt) dominate pathogenesis and double hit (mutation + CNV) represent ~18% cases. |
format | Online Article Text |
id | pubmed-7352311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73523112020-07-21 Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations Sprissler, Ryan Perkins, Bryce Johnstone, Laurel Babiker, Hani M. Chalasani, Pavani Lau, Branden Hammer, Michael Mahadevan, Daruka Cancers (Basel) Article Whole exome sequencing (WES) of matched tumor-normal pairs in rare tumors has the potential to identify genome-wide mutations and copy number alterations (CNAs). We evaluated 27 rare cancer patients with tumor-normal matching by WES and tumor-only next generation sequencing (NGS) as a comparator. Our goal was to: 1) identify known and novel variants and CNAs in rare cancers with comparison to common cancers; 2) examine differences between germline and somatic variants and how that functionally impacts rare tumors; 3) detect and characterize alleles in biologically relevant genes-pathways that may be of clinical importance but not represented in classical cancer genes. We identified 3343 germline single nucleotide variants (SNVs) and small indel variants—1670 in oncogenes and 1673 in tumor suppressor genes—generating an average of 124 germline variants/case. The number of somatic SNVs and small indels detected in all cases was 523:306 in oncogenes and 217 in tumor suppressor genes. Of the germline variants, six were identified to be pathogenic or likely pathogenic. In the 27 analyzed rare cancer cases, CNAs are variable depending on tumor type, germline pathogenic variants are more common. Cell fate pathway mutations (e.g., Hippo, Notch, Wnt) dominate pathogenesis and double hit (mutation + CNV) represent ~18% cases. MDPI 2020-06-18 /pmc/articles/PMC7352311/ /pubmed/32570879 http://dx.doi.org/10.3390/cancers12061618 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sprissler, Ryan Perkins, Bryce Johnstone, Laurel Babiker, Hani M. Chalasani, Pavani Lau, Branden Hammer, Michael Mahadevan, Daruka Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations |
title | Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations |
title_full | Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations |
title_fullStr | Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations |
title_full_unstemmed | Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations |
title_short | Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations |
title_sort | rare tumor-normal matched whole exome sequencing identifies novel genomic pathogenic germline and somatic aberrations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352311/ https://www.ncbi.nlm.nih.gov/pubmed/32570879 http://dx.doi.org/10.3390/cancers12061618 |
work_keys_str_mv | AT sprisslerryan raretumornormalmatchedwholeexomesequencingidentifiesnovelgenomicpathogenicgermlineandsomaticaberrations AT perkinsbryce raretumornormalmatchedwholeexomesequencingidentifiesnovelgenomicpathogenicgermlineandsomaticaberrations AT johnstonelaurel raretumornormalmatchedwholeexomesequencingidentifiesnovelgenomicpathogenicgermlineandsomaticaberrations AT babikerhanim raretumornormalmatchedwholeexomesequencingidentifiesnovelgenomicpathogenicgermlineandsomaticaberrations AT chalasanipavani raretumornormalmatchedwholeexomesequencingidentifiesnovelgenomicpathogenicgermlineandsomaticaberrations AT laubranden raretumornormalmatchedwholeexomesequencingidentifiesnovelgenomicpathogenicgermlineandsomaticaberrations AT hammermichael raretumornormalmatchedwholeexomesequencingidentifiesnovelgenomicpathogenicgermlineandsomaticaberrations AT mahadevandaruka raretumornormalmatchedwholeexomesequencingidentifiesnovelgenomicpathogenicgermlineandsomaticaberrations |